The expression of NGB was also reported to be down-regulated with increasing age, down-regulated in women (consistent with their increased risk), and up-regulated in the temporal lobe of AD patients (consistent with a response to the disease process) [21]. The gene discussed is NGB; the disease is Alzheimer disease.